LLY

770.04

+0.64%↑

JNJ

151.32

+1.12%↑

NVO

69.79

-5.51%↓

ABBV

183.89

-0.62%↓

UNH

300.76

-0.36%↓

LLY

770.04

+0.64%↑

JNJ

151.32

+1.12%↑

NVO

69.79

-5.51%↓

ABBV

183.89

-0.62%↓

UNH

300.76

-0.36%↓

LLY

770.04

+0.64%↑

JNJ

151.32

+1.12%↑

NVO

69.79

-5.51%↓

ABBV

183.89

-0.62%↓

UNH

300.76

-0.36%↓

LLY

770.04

+0.64%↑

JNJ

151.32

+1.12%↑

NVO

69.79

-5.51%↓

ABBV

183.89

-0.62%↓

UNH

300.76

-0.36%↓

LLY

770.04

+0.64%↑

JNJ

151.32

+1.12%↑

NVO

69.79

-5.51%↓

ABBV

183.89

-0.62%↓

UNH

300.76

-0.36%↓

Search

AcelRx Pharmaceuticals Inc

Geschlossen

0

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

Max

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+532.91% upside

AcelRx Pharmaceuticals Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

23. Juni 2025, 19:24 UTC

Wichtige Markttreiber

Amgen Expands MariTide Development Plans After Weight-Loss Trial -- Update

23. Juni 2025, 19:07 UTC

Wichtige Markttreiber

Amgen Expands MariTide Development Plans After Successful Weight-Loss Trial

23. Juni 2025, 17:29 UTC

Akquisitionen, Fusionen, Übernahmen

FTC Resolves Antitrust Probe Into Omnicom-Interpublic Merger

23. Juni 2025, 23:44 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

23. Juni 2025, 23:44 UTC

Market Talk

Nikkei May Rise as Fears About Israel-Iran Conflict Ease -- Market Talk

23. Juni 2025, 23:39 UTC

Market Talk

Gold Falls After Trump Says Israel, Iran Agree to Cease-Fire -- Market Talk

23. Juni 2025, 23:39 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

23. Juni 2025, 22:53 UTC

Market Talk

Global Equities Roundup: Market Talk

23. Juni 2025, 21:42 UTC

Ergebnisse

KB Home Cuts FY25 Outlook as 2Q Profit, Sales Fall -- Update

23. Juni 2025, 20:50 UTC

Market Talk
Ergebnisse

Basic Materials Roundup: Market Talk

23. Juni 2025, 20:30 UTC

Market Talk

Canada Employment Data May Be Overstating Job Gains -- Market Talk

23. Juni 2025, 20:24 UTC

Akquisitionen, Fusionen, Übernahmen

Tesla Stock Surges After Musk's Robo-Taxi Rollout. Where Shares Go From Here. -- Barrons.com

23. Juni 2025, 20:16 UTC

Market Talk

U.S. Stocks Climb After Iran's Retaliation Seen As Measured -- Market Talk

23. Juni 2025, 19:22 UTC

Market Talk

Oil Futures Sink As Iranian Retaliation Seen Weak -- Market Talk

23. Juni 2025, 18:56 UTC

Market Talk

U.S. Natural Gas Futures Settle Lower -- Market Talk

23. Juni 2025, 18:49 UTC

Market Talk

Gold Ticks Higher in Cautious Trade -- Market Talk

23. Juni 2025, 18:14 UTC

Market Talk

Global Energy Roundup: Market Talk

23. Juni 2025, 18:14 UTC

Market Talk

Treasury Yields, Dollar Little Changed on Iran's Retaliation -- Market Talk

23. Juni 2025, 17:59 UTC

Market Talk

Oil Futures Fall As Iran Fires Missiles At U.S. Bases in Qatar -- Market Talk

23. Juni 2025, 17:25 UTC

Market Talk

Services Lift Mexico's Economic Activity in April -- Market Talk

23. Juni 2025, 17:22 UTC

Market Talk

Weaker Oil Long-Term Looks to Keep a Lid on Grains -- Market Talk

23. Juni 2025, 17:20 UTC

Market Talk

Mexican Inflation Seen Easing in Early June --Market Talk -- Market Talk

23. Juni 2025, 16:27 UTC

Market Talk
Ergebnisse

Commercial Metals Says Tariffs, Interest Rates Won't Drag on Earnings -- Market Talk

23. Juni 2025, 16:23 UTC

Market Talk
Ergebnisse

Commercial Metals Sees Resilient Demand, Eyes Growth as Economic Uncertainty Eases -- Market Talk

23. Juni 2025, 16:20 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

23. Juni 2025, 16:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

23. Juni 2025, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

23. Juni 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

23. Juni 2025, 15:50 UTC

Akquisitionen, Fusionen, Übernahmen

Credit Agricole Didn't Disclose Financial Details

23. Juni 2025, 15:49 UTC

Akquisitionen, Fusionen, Übernahmen

Credit Agricole: Impact on Credit Agricole's CET1 Ratio Expected to Be Limited

Peer-Vergleich

Kursveränderung

AcelRx Pharmaceuticals Inc Prognose

Kursziel

By TipRanks

532.91% Vorteil

12-Monats-Prognose

Durchschnitt 5 USD  532.91%

Hoch 5 USD

Tief 5 USD

Basierend auf 1 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für AcelRx Pharmaceuticals Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

1 ratings

1

Buy

0

Halten

0

Sell

Finanzen

$